Patents by Inventor Jiali He

Jiali He has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11967718
    Abstract: A negative active material includes a carbon material. The carbon material satisfies the following relationship: 6<Gr/K<16, Gr is a graphitization degree of the carbon material, measured by X-ray diffraction; and K is a ratio Id/Ig of a peak intensity Id of the carbon material at a wavenumber of 1250 cm?1 to 1650 cm?1 to a peak intensity Ig of the carbon material at a wavenumber of 1500 cm?1 to 1650 cm?1, and is measured by using Raman spectroscopy, and K is 0.06 to 0.15.
    Type: Grant
    Filed: December 2, 2022
    Date of Patent: April 23, 2024
    Assignee: NINGDE AMPEREX TECHNOLOGY LIMITED
    Inventors: Lihong He, Jia Tang, Jiali Dong, Yuansen Xie
  • Patent number: 11936045
    Abstract: A negative active material includes a carbon material. The carbon material satisfies the following relationship: 6<Gr/K<16, Gr is a graphitization degree of the carbon material, measured by means of X-ray diffraction; and K is a ratio Id/Ig of a peak intensity Id of the carbon material at a wavenumber of 1250 cm?1 to 1650 cm?1 to a peak intensity Ig of the carbon material at a wavenumber of 1500 cm?1 to 1650 cm?1, and is measured by using Raman spectroscopy, and K is 0.06 to 0.15. The negative active material according to this application can significantly improve an energy density, cycle performance, and rate performance of the electrochemical device.
    Type: Grant
    Filed: February 23, 2023
    Date of Patent: March 19, 2024
    Assignee: Ningde Amperex Technology Limited
    Inventors: Lihong He, Jia Tang, Jiali Dong, Yuansen Xie
  • Publication number: 20220395505
    Abstract: A solid pharmaceutical composition comprising a quinazoline derivative or a medicinal salt thereof, and a preparation method therefor. Specifically, provided is a solid pharmaceutical composition comprising N6-(1-acryloylpiperidin-4-yl)-N4-(3-chloro-4-fluorophenyl)-7-methoxyquinazoline-4,6-diamine or a medicinal salt thereof, and a preparation method therefor and use thereof.
    Type: Application
    Filed: October 30, 2020
    Publication date: December 15, 2022
    Inventors: Lei Shang, Jiali He, Caixia Yan, Ping Dong, Jie Zhou, Yingying Sun, Yi Xu, Zhilin Chen, Song Tang